We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Yep, don't think many problems, here. If price goes lower and funds available, just buy more IMO.
Nah the pipeline is so full of new compounds I expect a fair bit of growth in the company over the coming few years
Technical analysis is no more than a measurement of fickle sentiment by those who have never run a business in their life and want to appear to know what they are doing. It is no better than astrology in that those who believe in it distort the world around them. Currently I can see an upside down, exponential differentiation in the reverse ass and hips coefficient pattern when viewed through said ass with a high of 95 and a low of 120 sp
Don't think you will find a receptive audience to this message here.....you do know you are on a forum for people investing with the sole purpose of generating wealth for themselves?
The person at the top should be disgusting with himself for taking what could be eighteen million pay check, greed is a horrible desease, just remember you come in with a bare ass and you leave with one, I hope you put the money to a good cause, I doubt very much you will,the more you get the more you want, money does not bring you happiness please remember this!
I suppose if you have paid good money and/or wasted countless hours studying this sort of thing you have believe in it. However, I think it is glorious old general hindsight, the best strategist on the battlefield. Essentially the financial equivalent of homeopathy. Totally useless :-)
Now that you mention the head and shoulders, bearish sp, formation, unless AZN, can hold above the support at 9900, which it is now recovered , the head and shoulders price formation , would provide a price target of below 8000.
Thank you for being observant.
It's gone up a bit then, but nobody (including you) has the slightest idea why. Maybe it will form a cup handle or start using head & shoulders. LOL
AZN, made a sp, trough on 12/2/24, which broke price support. However the sector chart displayed no such weakness.
Volume today, on the rally was the lowest volume, in 9 days, although previous broken price support was recovered. Sp, has broken above short term down trendline of yesterday at 10384. However major down trendline at 10750, is still ahead. There is recent overhead supply from previous trading at 10500, which can be expected to impede upward sp, progress. The high price of 10498, today , would seem to support that conclusion. The sp, today , has broken above the Fibonacci retracement level of 61.8%, at 10365. A two day close above 10365, would reduce chance of retracement bearing in mind the low volume today .
Hardman & Co
Seven companies accounted for most deals .
46% of deals by seven companies Deals were led by the major pharmaceutical companies. In 2023, 46% of all deals were announced by just seven companies, representing 79% of the total consideration.
Major pharma M&A activity – 2023
Acquiror.... Ticker......... # deals Total consideration ($m)
Pfizer PFE ...........................1.... 43,000
Bristol Myers Squibb BMY.. 3 ...22,900
AbbVie ABBV....................... 2.. 18,800
Merck & Co MRK................. 1.. 10,800
Eli Lilly LLY ..........................4... 5,760
Novartis NVS...................... 2... 3,700
AstraZeneca AZN............... 3... 3,338
Hardman & Co
Despite generating a fairly regular flow of news, AstraZeneca (AZN) underperformed the UK index for the first time in several years. It had some disappointments in its R&D pipeline and some of its more recently launched drugs have not seen the expected growth rates given their strong early commercial uptake seen in 2022.
Noveck ...no problem, I was playing at being pedantic.
Ref' AZN sp....I hope you're wrong but, like many, I'm very
p€€d off at the ftse performance overall. Investing culture on a big downward trend in this depressing, demoralising country and not much sign of any improvement....no matter who 'governs ' us. Good luck to us all in every aspect of our lives and my grandkids future.
Good point well made Yam..
£120+ to £80 something, my bad.
Still not cheap and will get cheaper - time will tell innit...
Noveck.... being as you like to be "accurate " why do you say £12 ? Surely you meant £120. D!{k. LOL
I just see this being range bound for a while…..buy below 100, sell at 110. (Obviously NFG will set these bounds lower - each top their own).
Grayling, you're a yappy, clueless keyboard warrior PR1(CK).
I'm a little more accurate in my prediction of a downtrend on this overvalued nonsense than you've been.
I said it would drop significantly when it was over £12 share, and it's massively underperformed the market since. It's now less than 10% from having an 8 in front of the share price as I said it would..
Empty vessels make the most noise..!
And precisely which company do you think would make the largest takeover ever by bidding for AZN?
I do not recall the Share price rocketing on the back of COVID, if anything it did the opposite, the price started rising once COVID was over and everything started getting back to normal.
Yes I hold astra shares but unfortunately anything with plc at the end takes a beating if there's any disappointment to latch onto...
Mr Market thinks otherwise. Number crunching overnight will result in more movements tomorrow. Which way is anyone's guess.
Pretty good financial report overall from Astrazeneca. The future prospects look good with the oncology side of the business absolutely flying.
Russ. Seems daft to me but this share is a long term hold.
Does £6.50?
That clown Noveckingood will be back soon telling us that AZN is grossly overvalued and he will be back in when it drops into the 800’s. LOL
Entirely predictable given the current febrile market and they did miss their target. It will settle back down and at least the reason for some of the lower profits was increased R&D expenditure ie. Reinvesting profits for future growth.